Cargando…
Differential ammonia decay kinetics indicates more than one concurrent etiological mechanism for symptomatic hyperammonemia caused by valproate overdose
Valproic acid (VPA) has successfully been used in the therapy of a number of conditions including absence seizures, partial seizures, tonic-clonic seizures, bipolar disorder, schizoaffective disorder, social phobias, neuropathic pain and migraine headaches. There is a high rise in number of cases of...
Autores principales: | Mojumder, Deb Kumar, De Oleo, Radhames Ramos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071718/ https://www.ncbi.nlm.nih.gov/pubmed/24987188 http://dx.doi.org/10.4103/0253-7613.132200 |
Ejemplares similares
-
Valproate-induced encephalopathy with predominant pancerebellar syndrome
por: Verma, Rajesh, et al.
Publicado: (2012) -
Sodium Valproate induced priapism in an adult with bipolar affective disorder
por: Bansal, Shwetank, et al.
Publicado: (2013) -
Dose-dependent valproate-induced alopecia in patients with mental disorders
por: Tomita, Takashi, et al.
Publicado: (2015) -
Serum drug level-related sodium valproate-induced hair loss
por: Ramakrishnappa, Suresh K., et al.
Publicado: (2013) -
Hypoglycemia - A rare complication of carbamazepine overdose
por: Jha, Avanish, et al.
Publicado: (2014)